Liver function and drug processing: a closer look at MCI-186
NCT ID NCT03289234
First seen Jan 11, 2026 · Last updated May 13, 2026 · Updated 14 times
Summary
This study looked at how the drug MCI-186 is processed in people with mild or moderate liver problems compared to healthy people. A total of 22 adults received a single dose of the drug through an IV. The goal was to see if liver function changes how the drug moves through the body. This helps doctors understand safe dosing for patients with liver issues.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEALTHY are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Investigational site
Fukuoka, Japan
-
Investigational site
Tokyo, Japan
Conditions
Explore the condition pages connected to this study.